Administration of granulocyte-colony stimulating factor accompanied with a balanced diet improves cardiac function alterations induced by high fat diet in mice

BMC Cardiovascular Disorders

Volumn 15, Issue 1, 2015, Pages

  Daltro, Pâmela Santana ^a   Alves, Paula Santana ^b   Castro, Murilo Fagundes ^a   Azevedo, Carine M ^b   Vasconcelos, Juliana Fraga ^c   Allahdadi, Kyan James ^a   de Freitas, Luiz Antônio Rodrigues ^b,c   de Freitas Souza, Bruno Solano ^a,b   dos Santos, Ricardo Ribeiro ^a   Soares, Milena Botelho Pereira ^a,b   Macambira, Simone Garcia ^a,b,c  

^a HOSPITAL SÃO RAFAEL   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Diabetes; Diabetic cardiomyopathy; G CSF; Obesity

Indexed keywords

CHOLESTEROL; GLUCOSE; GRANULOCYTE COLONY STIMULATING FACTOR; INSULIN; LIPID; ADIPONECTIN; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BRADYCARDIA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE; GLUCOSE TOLERANCE; HEART; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART OUTPUT; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; LIPID DIET; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITIONAL ASSESSMENT; OBESITY; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; TREADMILL TEST; ANIMAL; BLOOD; C57BL MOUSE; CARDIAC MUSCLE; COMPLICATION; DIABETIC CARDIOMYOPATHIES; DISEASE MODEL; FIBROSIS; GLUCOSE BLOOD LEVEL; HEMODYNAMICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FIBROSIS; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMODYNAMICS; INSULIN; MALE; MICE, INBRED C57BL; MYOCARDIUM; OBESITY;

EID: 84949204668     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/s12872-015-0154-6     Document Type: Article

References (50)

1. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378(9785):31-40. doi: 10.1016/S0140-6736(10)62037-5.
2. Global status report on noncommunicable diseases 2010. Geneva, World Health Organization. 2011. http://www.who.int/nmh/publications/ncd_report_full_en.pdf.
3. de Simone G, Devereux RB, Chinali M, Lee ET, Galloway JM, Barac A, et al. Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study. J Hypertens. 2010;28(2):353-60. doi: 10.1097/HJH.0b013e3283331169.
4. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30(6):595-602.
5. Akki A, Seymour AM. Wesern diet impairs metabolic remodeling and contractile efficiency in cardiac hypertrophy. Cardiovasc Res. 2009;81(3):610-7. doi: 10.1093/cvr/cvn316.
6. Pagano C, Calcagno A, Granzotto M, Calabrese F, Thiene G, Federspil G, et al. Eart lipid accumulation in obese non-diabetic rats: effect of weight loss. Nutr Metab Cardiovasc Dis. 2008;18(3):189-97.
7. Buchanan J, Mazumder PK, Hu P, Chakrabarti G, Roberts MW, Yun UJ, et al. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology. 2005;146(12):5341-9.
8. Eckel RH, Kahn SE, Ferrannini E, Goldfine AB, Nathan DM, Schwartz MW, et al. Obesity and type 2 diabetes: what Can Be unified and what needs to Be individualized? Diabetes Care. 2011;34(6):1424-30. doi: 10.2337/dc11-0447.
9. Westermann D, Rutschow S, Jager S, Linderer A, Anker S, Riad A, et al. Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy. Diabetes. 2007;56(3):641-6.
10. Ko HJ, Zhang Z, Jung DY, Jun JY, Ma Z, Jones KE, et al. Nutrient stress activates inflammation and reduces glucose metabolism by suppressing AMPK in heart. Diabetes. 2009;58(11):2536-46. doi: 10.2337/db08-1361.
11. Haugen E, Chen J, Wikstrom J, Grönros J, Gan LM, Fu LX. Parallel gene expression of IL-6 and BNP during cardiac hypertrophy complicated with diastolic dysfunction in spontaneously hypertensive rats. Int J Cardiol. 2007;115(1):24-8.
12. Avogaro A, Albiero M, Menegazzo L, De Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care. 2011;34(2):285-90. doi: 10.2337/dc11-s239.
13. Avogaro A, De Kreutzenberg SV, Fadini GP. Oxidative stress and vascular disease in diabetes: is the dichotomization of insulin signaling still valid? Free Radic Biol Med. 2008;44(6):1209-15. doi: 10.1016/j. freeradbiomed.2007.12.021.
14. Avogaro A, De Kreutzenberg SV, Fadini GP. Endothelial dysfunction: Causes and consequences in patients with diabetes mellitus. Diabetes Res Clin Pract. 2008;82(2):94-101. doi: 10.1016/j.diabres.2008.09.021.
15. Nonino-Borges CB, Borges RM, Santos JE. Tratamento clínico da obesidade. Medicina. 2006;39(2):246-52.
16. Delgaudine M, Gothot A, Beguin Y. Spontaneous and granulocyte-colony-stimulating factor-enhanced marrow response and progenitor cell mobilization in mice after myocardial infarction. Cytotherapy. 2010;12(7):909-18. doi: 10.3109/14653240903580262.
17. Link DC. Mechanisms of granulocyte colonystimulating factor-induced hematopoietic progenitor-cell mobilization. Semin Hematol. 2000;37(2):25-32.
18. Theiss HD, Gross L, Vallaster M, David R, Brunner S, Brenner C, et al. Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction. Int J Cardiol. 2013;168(4):3359-69. doi: 10.1016/j.ijcard.2013.04.121.
19. Fazel S, Cimini M, Chen L, Li S, Angoulvant D, Fedak P, et al. Cardioprotective c-kit+cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest. 2006;116(7):1865-77.
20. Ott HC, Taylor DA. From cardiac repair to cardiac regeneration - ready to translate? Expert Opin Biol Ther. 2006;6(9):867-78.
21. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001;7(4):430-6. doi: 10.1038/86498.
22. Macambira SG, Vasconcelos JF, Costa CRS, Klein W, Lima RS, Guimarães P, et al. Granulocyte colony-stimulating factor treatment in chronic Chagas disease: preservation and improvement of cardiac structure and function. FASEB J. 2009;23(11):3843-50. doi: 10.1096/fj.09-137869.
23. Ghanem A, Röll W, Hashemi T, Dewald O, Djoufack PC, Fink KB, et al. Echocardiographic assessment of left ventricular mass in neonatal and adult mice: accuracy of different echocardiographic methods. Echocardiography. 2006;23(10):900-7.
24. Stypmann J. Doppler ultrasound in mice. Echocardiography. 2007;24(1):97-112.
25. Berul CI, Aronovitz MJ, Wang PJ, Mendelsohn ME. In vivo cardiac electrophysiology studies in the mouse. Circulation. 1996;94:2641-8.
26. Vasconcelos JF, Souza BS, Lins TF, Garcia LM, Kaneto CM, Sampaio GP, et al. Administration of granulocyte colony-stimulating factor induces immunomodulation, recruitment of T regulatory cells, reduction of myocarditis and decrease of parasite load in a mouse model of chronic Chagas disease cardiomyopathy. FASEB J. 2013;27(12):4691-702. doi: 10.1096/fj.13-229351.
27. Pi-Sunyer FX, Maggio CA, McCarron DA, Reusser ME, Stern JS, Haynes RB, et al. Multicenter randomized trial of a comprehensive prepared meal program in type 2 diabetes. Diabetes Care. 1999;22(2):191-7.
28. Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2013;36:3821-42.
29. van Horn L, McCoin M, Kris-Etherton PM, Burke F, Carson JA, Champagne CM, et al. Potential mechanisms and needs for future research are summarized for each relevant nutrient, food, or food component. J Am Diet Assoc. 2008;108(2):287-331.
30. Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia. 2014;57(4):660-71. doi: 10.1007/s00125-014-3171-6.
31. Rato Q. Diabetes mellitus: um problema de saúde global. Rev Port Cardiol. 2010;29(04):539-43.
32. Cheng D. Prevalence, predisposition and prevention of type II diabetes. Nutr Metab. 2005;2:29-41.
33. Aronne LJ, Isoldi KK. Overweight and obesity: Key components of cardiometabolic risk. Clin Cornerstone. 2007;8(3):29-37.
34. Prpic V, Watson PM, Frampton IC, Sabol MA, Jezek GE, Gettys TW. Differential mechanisms and development of leptin resistance in A/J versus C57BL/6 J mice during diet-induced obesity. Endocrinology. 2003;144(4):1155-63.
35. Noonan WT, Banks RO. Renal function and glucose transport in male and female mice with diet-induced type II diabetes mellitus. Proc Soc Exp Biol Med. 2000;225(3):221-30.
36. Rebuffé-Scrive M, Sutwit R, Feinglos M, Kuhn C, Rodin J. Regional fat distribution and metabolism in a new mouse model (C57BL/6 J) of non-insulin-dependent diabetes mellitus. Metabolism. 1993;42(11):1405-9.
37. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2011;34(5):S11-61. doi: 10.2337/dc11-0174.
38. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364-79. doi: 10.2337/dc12-0413.
39. Mehran AE, Templeman NM, Brigidi GS, Lim GE, Chu KY, Hu X, et al. Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metab. 2012;16:723-37. doi: 10.1016/j.cmet.2012.10.019.
40. Lee Y, Song YS, Fang CH, So BI, Park JY, Joo HW, et al. Anti-obesity effects of granulocyte-colony stimulating factor in Otsuka-Long-Evans-Tokushima fatty rats. PLoS One. 2014;9(8):e105603. doi: 10.1371/journal.pone.0105603.
41. Linden MA, Pincu Y, Martin SA, Woods JA, Baynard T. Moderate exercise training provides modest protection against adipose tissue inflammatory gene expression in response to high-fat feeding. Phys Rep. 2014;2:e12071. doi:10.14814/phy2.12071.
42. Minatoguchi S, Takemura G, Chen XH, Wang N, Uno Y, Koda M, et al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation. 2004;109:2572-80.
43. Sugimoto C, Fujieda S, Sunaga H, Noda I, Tanaka N, Kimura Y, et al. Granulocyte colony-stimulating factor (G-CSF)-mediated signaling regulates type IV collagenase activity in head and neck cancer cells. Int J Cancer. 2001;93(1):42-6. doi: 10.1002/ijc.1297.
44. Woodiwiss AJ, Libhaber CD, Majane OH, Libhaber E, Maseko M, Norton GR. Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure. Am J Hypertens. 2008;21(10):1144-51. doi: 10.1038/ajh.2008.252.
45. Szardien S, Nef HM, Voss S, Troidl C, Liebetrau C, Hoffmann J, et al. Regression of cardiac hypertrophy by granulocyte colony-stimulating factor-stimulated interleukin-1β synthesis. Eur Heart J. 2012;33(5):595-605. doi: 10.1093/eurheartj/ehr434.
46. Huber BC, Beetz NL, Laskowski A, Ziegler T, Grabmaier U, Kupatt C, et al. Attenuation of cardiac hypertrophy by G-CSF is associated with enhanced migration of bone marrow-derived cells. J Cell Mol Med. 2015;19(5):1033-41. doi: 10.1111/jcmm.12494.
47. Littlejohns B, Pasdois P, Duggan S, Bond AR, Heesom K, Jackson CL, et al. Hearts from mice Fed a Non-obesogenic high-Fat diet exhibit changes in their oxidative state, calcium and mitochondria in parallel with increased susceptibility to reperfusion injury. PLoS One. 2014;9(6):e100579. doi: 10.1371/journal.pone.0100579.
48. Van Empel VP, De Windt LJ. Myocyte hypertrophy and apoptosis: a balancing act. Cardiovasc Res. 2004;63(3):487-99.
49. Harvey PA, Leinwand LA. The cell biology of disease: cellular mechanisms of cardiomyopathy. J Cell Biol. 2011;194(3):355-65. doi: 10.1083/jcb.201101100.
50. Li Y, Takemura G, Okada H, Miyata S, Esaki M, Maruyama R, et al. Treatment with granulocyte colony-stimulating factor ameliorates chronic heart failure. Lab Invest. 2006;86(1):32-44.